Swetha Kambhampati Profile
Swetha Kambhampati

@SwethaKMD

Followers
476
Following
841
Media
16
Statuses
285

Assistant Professor at City of Hope; Alum: UCSF heme/onc, Hopkins IM, Stanford Med; Interested in lymphoma and CART

Los Angeles, CA
Joined February 2010
Don't wanna be here? Send us removal request.
@grok
Grok
21 hours
Generate videos in just a few seconds. Try Grok Imagine, free for a limited time.
432
182
2K
@SwethaKMD
Swetha Kambhampati
2 years
0
0
0
@SwethaKMD
Swetha Kambhampati
2 years
0
0
0
@SwethaKMD
Swetha Kambhampati
2 years
RT @cityofhope: Developing the treatments of tomorrow is hard work. @DoctorAKrishnan, M.D., and @elizabeth_budde, M.D., Ph.D., are leading….
0
2
0
@SwethaKMD
Swetha Kambhampati
2 years
RT @Blood_Cancers: Axicabtagene ciloleucel showed a significant improvement in OS over standard of care in patients with relapsed or refrac….
0
1
0
@SwethaKMD
Swetha Kambhampati
2 years
RT @Blood_Cancers: 🔊OUT NOW: This all-new episode of The HemOnc Pulse features host @chadinabhan speaking with @SwethaKMD of @cityofhope an….
0
4
0
@SwethaKMD
Swetha Kambhampati
2 years
RT @Lymphoma_Doc: Huge news! ZUMA-7 trial shows axi-cel improves overall survival in patients with second-line aggressive lymphoma, compare….
0
8
0
@SwethaKMD
Swetha Kambhampati
2 years
RT @GCC_Cortes: Dr. Ayushi Chauhan @Chauhan_AF from @GACancerCenter named the 2023 Stephanie A. Gregory Distinguished Scholar by the Lympho….
0
3
0
@SwethaKMD
Swetha Kambhampati
2 years
RT @Blood_Cancers: 🔊Coming Thursday, 3/23: An all-new episode of The HemOnc Pulse features host @chadinabhan speaking with @SwethaKMD of @c….
0
5
0
@SwethaKMD
Swetha Kambhampati
2 years
RT @ColtonLadbury: Excited the City of Hope experience with bridging therapy prior to CAR T for LBCL is published. Thanks for the collabora….
0
4
0
@SwethaKMD
Swetha Kambhampati
2 years
Phenomenal and inspirational week at LRF LSRMP! great mentorship and developed life long friendships and connections! Grateful for the experience @lymphoma @cityofhope.
@tvoorheesmd
Timothy Voorhees, MD, MSCR
2 years
Amazing week with LRF LSRMP at Lake Las Vegas. Great protocol development. Meeting mentors and colleagues was invaluable! @lymphoma @OSUHematology
Tweet media one
Tweet media two
Tweet media three
Tweet media four
0
1
14
@SwethaKMD
Swetha Kambhampati
2 years
RT @DanilovLab: Great group at the LRF Sci Res Mentoring Program in Las Vegas @DrCarlaCasulo @SwethaKMD
Tweet media one
0
1
0
@SwethaKMD
Swetha Kambhampati
2 years
RT @VJHemOnc: #Tandem23 | @SwethaKMD of @cityofhope discusses real-world outcomes of patients with transformed R/R DLBCL treated with CAR-T….
0
3
0
@SwethaKMD
Swetha Kambhampati
2 years
RT @Blood_Cancers: Pola-R-CHP can be more cost-effective than R-CHOP in patients with treatment-naïve DLBCL in certain circumstances, accor….
Tweet card summary image
bloodcancerstoday.com
Polatuzumab in combination with chemotherapy may be cost-effective for some cancers.
0
1
0